Professor, Bioengineering, McGill University
Canada Research Chair in Bioprocessing of Viral Vaccines
Dr. Amine Kame is Researcher Emeritus of the National Research Council of Canada (NRC) where he was employed until early 2014, as head of the Process Development section of the Human Health Therapeutics Portfolio. At NRC, he established one of the North America largest and most advanced governmental center for animal cell culture addressing process development and scale up of biologics. Also, he developed with his team and licensed to industry multiple technology platforms for efficient manufacturing of recombinant proteins and viral vectors and vaccines and led technology transfer to manufacturing sites for clinical evaluation and commercialization. His current research activities focus on uncovering mechanisms associated with cell production of viral vectors and viral vaccines; cell and metabolic engineering; process control and monitoring; and process analytical technologies of high yield productions of viral vectors for gene delivery and vaccination. He trained and mentored more than 40 PhDs, post-Docs fellows and Research associates. He published over one hundred and thirty papers in refereed international journals and acts as consultant for several national and international private and public organizations, including the Gates Foundation and WHO.